Ionis Pharmaceuticals Inc. Common Stock vs Lowe`s Companies Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Lowe`s Companies Inc trades at $189.09 (market cap $105.89B). The key difference: Lowe`s Companies Inc is far larger — about 15× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Lowe`s Companies Inc pays a 2.65% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Lowe`s Companies Inc for 98 Days on average.
| IONS | LOW | |
|---|---|---|
Market Cap | $7.04B | $105.89B |
Volume | 2,977,440 | 3,104,115 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $287.39 |
52-Week Low | $42.38 | $179.50 |
Typical Hold Time | 0 Days | 98 Days |
Enterprise Value | $6.60B | $144.74B |
Dividend Yield | — | 2.65% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lowe's (LOW) trades at $188.36, up 1.5% with recent earnings beats but facing industry headwinds. The stock shows bearish technical signals despite positive analyst sentiment with a $244.09 consensus target. Revenue declined to $83.67B in 2025, though net margins remain healthy at 7.35%. Recent drone delivery initiatives with DoorDash and Alphabet aim to enhance competitiveness amid a challenging home improvement market.
LOW presents a value opportunity with reasonable P/E (15.95) and strong cash flow, but risks include declining revenue trends, high debt levels, and housing market sensitivity. Wall Street maintains bullish ratings (61% buy) despite near-term pressure, suggesting potential upside if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →